CytoDyn Inc. (CYDY)
OTCMKTS: CYDY · Delayed Price · USD
0.155
+0.004 (2.75%)
Apr 19, 2024, 3:59 PM EDT - Market closed
CytoDyn Balance Sheet
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 2.54 | 4.23 | 33.94 | 14.28 | 2.61 | 1.23 | 1.78 | 9.64 | 1.05 | 4.89 | Upgrade
|
Cash & Cash Equivalents | 2.54 | 4.23 | 33.94 | 14.28 | 2.61 | 1.23 | 1.78 | 9.64 | 1.05 | 4.89 | Upgrade
|
Cash Growth | -39.94% | -87.53% | 137.67% | 446.59% | 112.18% | -30.65% | -81.58% | 818.21% | -78.51% | 709.39% | Upgrade
|
Receivables | 0 | 17.93 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Inventory | 0 | 17.93 | 93.48 | 19.15 | -0.09 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 8.26 | -11.65 | 2.16 | 3.4 | 2.76 | 2.09 | 4.35 | 1.85 | 0.99 | 0.56 | Upgrade
|
Total Current Assets | 10.81 | 28.44 | 129.58 | 36.83 | 5.37 | 3.32 | 6.12 | 11.49 | 2.04 | 5.44 | Upgrade
|
Property, Plant & Equipment | 0.4 | 0.61 | 0.85 | 0.23 | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Intangible Assets | 0 | 0.13 | 1.65 | 13.46 | 15.48 | 1.57 | 1.92 | 2.27 | 2.62 | 2.97 | Upgrade
|
Other Long-Term Assets | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 0.49 | 0.74 | 2.5 | 13.69 | 15.5 | 1.58 | 1.93 | 2.29 | 2.64 | 2.98 | Upgrade
|
Total Assets | 11.29 | 29.19 | 132.08 | 50.51 | 20.87 | 4.9 | 8.06 | 13.79 | 4.68 | 8.43 | Upgrade
|
Accounts Payable | 62.73 | 67.97 | 65.9 | 29.48 | 16.24 | 15.84 | 4.28 | 2.47 | 5.02 | 1.29 | Upgrade
|
Deferred Revenue | 22.58 | 0 | 0 | 8.15 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt | 34.42 | 36.38 | 62.92 | 6.86 | 7.79 | 0 | 1.06 | 0 | 1.63 | 0 | Upgrade
|
Other Current Liabilities | 0.08 | 18.81 | 23.73 | 0.01 | 2.9 | 0.89 | 0.8 | 1.11 | 4.07 | 0.88 | Upgrade
|
Total Current Liabilities | 119.8 | 123.16 | 152.55 | 44.5 | 26.93 | 16.73 | 6.14 | 3.58 | 10.73 | 2.17 | Upgrade
|
Long-Term Debt | 1 | 0.42 | 0.55 | 8.49 | 0.45 | 0 | 0 | 0 | 2.64 | 2.34 | Upgrade
|
Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 2.41 | 1.32 | 3.01 | 2.47 | 2.01 | 0 | Upgrade
|
Total Long-Term Liabilities | 1 | 0.42 | 0.55 | 8.49 | 2.86 | 1.32 | 3.01 | 2.47 | 4.65 | 2.34 | Upgrade
|
Total Liabilities | 120.79 | 123.58 | 153.1 | 52.99 | 29.79 | 18.06 | 9.16 | 3.58 | 15.37 | 4.51 | Upgrade
|
Total Debt | 35.41 | 36.8 | 63.47 | 15.35 | 8.24 | 0 | 1.06 | 0 | 4.27 | 2.34 | Upgrade
|
Debt Growth | -3.76% | -42.03% | 313.43% | 86.31% | - | - | - | - | 82.67% | 17.50% | Upgrade
|
Common Stock | 0.92 | 0.72 | 0.63 | 0.52 | 0.33 | 0.22 | 0.15 | 0.12 | 35.82 | 30.37 | Upgrade
|
Retained Earnings | -841.69 | -766.13 | -511.29 | -354.71 | -229.36 | -173.14 | -122.99 | -97.23 | -71.52 | -46.43 | Upgrade
|
Comprehensive Income | 0 | 0 | -2.65 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shareholders' Equity | -109.5 | -94.4 | -21.02 | -2.48 | -8.91 | -13.16 | -1.1 | 10.21 | -10.69 | 3.92 | Upgrade
|
Total Liabilities and Equity | 11.29 | 29.19 | 132.08 | 50.51 | 20.87 | 4.9 | 8.06 | 13.79 | 4.68 | 8.43 | Upgrade
|
Net Cash / Debt | -32.87 | -32.57 | -29.53 | -1.07 | -5.63 | 1.23 | 0.72 | 9.64 | -3.22 | 2.55 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | 71.76% | -92.56% | - | - | - | Upgrade
|
Net Cash Per Share | -0.04 | -0.05 | -0.05 | -0.00 | -0.02 | 0.01 | 0.01 | 0.10 | -0.06 | 0.05 | Upgrade
|
Working Capital | -108.99 | -94.72 | -22.97 | -7.67 | -21.56 | -13.41 | -0.02 | 7.91 | -8.69 | 3.28 | Upgrade
|
Book Value Per Share | -0.13 | -0.14 | -0.04 | -0.01 | -0.03 | -0.08 | -0.01 | 0.11 | -0.18 | 0.08 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.